مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

5,726
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

VAGINAL MISOPROSTOL FOR CERVICAL PRIMING BEFORE HYSTEROSCOPY

Pages

  599-603

Abstract

 Background: As an important diagnostic and therapeutic procedure for patients with intrauterine diseases, HYSTEROSCOPY permits a good view of the uterine cavity, thereby increasing diagnostic accuracy. Complications often encountered during HYSTEROSCOPY primarily concern problems with CERVICAL DILATATION and include uterine perforation, cervical tears, and the creation of false tracts. In this study, we investigate the utility of vaginal MISOPROSTOL for CERVICAL DILATATION in women undergoing HYSTEROSCOPY. Methods: This triple-blind, randomized, placebo-controlled study was carried out at Mirza Khoochak Khan Hospital, Tehran, Iran. We excluded women who were pregnant, had genital tract infection, or history of cervical trauma. We randomly assigned 80 women with abnormal uterine bleeding or intrauterine lesions to receive either 200 mg vaginal MISOPROSTOL or placebo. Ten to twelve hours prior to HYSTEROSCOPY, the placebo or MISOPROSTOL was administered to the posterior vaginal fornix. Data regarding cervical response and outcome of operative HYSTEROSCOPY, as well as complications, were analyzed. Results: The mean cervical width, as estimated by Hegar dilator, was significantly greater in the treated group (7.8±1.6mm) than that in the control group (5.6±2.2mm, p<0.001). In the MISOPROSTOL group, 28 (70%) patients required CERVICAL DILATATION, compared with 38(95%) in the placebo group (p=0.001). A significantly shorter median time of CERVICAL DILATATION to Hegar number 9 was found in the treated subjects than in the controls (60 vs. 180 seconds, p<0.001). The mean operative time was significantly shorter in the treated group (8.8±8.7 minutes) compared with that of the control group (13.1±10.1 minutes, p=0.043). Conclusions: Vaginal MISOPROSTOL before operative HYSTEROSCOPY lessens the need for CERVICAL DILATATION, facilitating hysteroscopic surgery.

Cites

References

  • No record.
  • Cite

    APA: Copy

    VALADAN, M., REZAEI, ZAHRA, MOHAMMADPOUR, ZH., & MOGHADAMI TABRIZI, N.. (2008). VAGINAL MISOPROSTOL FOR CERVICAL PRIMING BEFORE HYSTEROSCOPY. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), 66(8), 599-603. SID. https://sid.ir/paper/38779/en

    Vancouver: Copy

    VALADAN M., REZAEI ZAHRA, MOHAMMADPOUR ZH., MOGHADAMI TABRIZI N.. VAGINAL MISOPROSTOL FOR CERVICAL PRIMING BEFORE HYSTEROSCOPY. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ)[Internet]. 2008;66(8):599-603. Available from: https://sid.ir/paper/38779/en

    IEEE: Copy

    M. VALADAN, ZAHRA REZAEI, ZH. MOHAMMADPOUR, and N. MOGHADAMI TABRIZI, “VAGINAL MISOPROSTOL FOR CERVICAL PRIMING BEFORE HYSTEROSCOPY,” TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), vol. 66, no. 8, pp. 599–603, 2008, [Online]. Available: https://sid.ir/paper/38779/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button